<DOC>
<DOCNO>EP-0657171</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Endoparasiticide drugs based upon open chain octadepsipeptides
</INVENTION-TITLE>
<CLASSIFICATIONS>C07K700	A61K3122	C07K706	A61K3121	A61P3300	A61P3310	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07K	A61K	C07K	A61K	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07K7	A61K31	C07K7	A61K31	A61P33	A61P33	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to the use of open-chain octadepsipeptides of the general formula (I) 
<
IMAGE
>
 and their optical isomers and racemates, for controlling endoparasites in human and veterinary medicine.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
BAYER AG
</APPLICANT-NAME>
<APPLICANT-NAME>
BAYER AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
HARDER ACHIM DR
</INVENTOR-NAME>
<INVENTOR-NAME>
JESCHKE PETER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
MENCKE NORBERT DR
</INVENTOR-NAME>
<INVENTOR-NAME>
PLANT ANDREW DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHERKENBECK JUERGEN DR
</INVENTOR-NAME>
<INVENTOR-NAME>
HARDER, ACHIM, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
JESCHKE, PETER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
MENCKE, NORBERT, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
PLANT, ANDREW, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHERKENBECK, JUERGEN, DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of the open-chain octadepsipeptides of the
general formula (I)



in which

A
represents hydrogen, alkyl, aralkyl or an acyl
radical, in particular a radical of the formula

-CO-R
15
 in which
R
15
represents straight-chain or branched alkyl,
alkenyl, alkoxy, aralkyl or arylalkoxy having

up to 6 carbon atoms in the alkyl moiety, 
R
1
, R
4
, R
7
 and R
10
independently of one another
represent C
1
-C
8
-alkyl, C
3
-C
6
-cycloalkyl
or aralkyl,
R
2
, R
5
, R
8
 and R
11
independently of one another
represent hydrogen, straight-chain

or branched alkyl having up to 8
carbon atoms, hydroxyalkyl, alkanoyloxyalkyl,

alkoxyalkyl, aryloxyalkyl,
mercaptoalkyl,

alkylthioalkyl, alkylsulphinylalkyl,
alkylsulphonylalkyl,

carboxyalkyl, alkoxycarbonylalkyl,
arylalkoxycarbonylalkyl,

carbamoylalkyl, aminoalkyl, alkylaminoalkyl,
dialkylaminoalkyl,

guanidinoalkyl, which can
optionally be substituted by one

or two benzyloxycarbonyl radicals
or by one, two, three or four

alkyl radicals, or represent
alkoxycarbonylaminoalkyl, 9-fluorenylmethoxycarbonyl(Fmoc)aminoalkyl,

alkenyl, cycloalkyl, cycloalkylalkyl
and optionally substituted

arylalkyl, substituents
which may be mentioned being

halogen, hydroxyl, alkyl and
alkoxy, 
R
3
, R
6
, R
9
 and R
12
independently of one another
represent hydrogen, straight-chain

or branched alkyl having up to 8
carbon atoms, hydroxyalkyl, alkanoyloxyalkyl,

alkoxyalkyl,
aryloxyalkyl, alkylthioalkyl,

alkylsulphinylalkyl, alkylsulphonylalkyl,
carboxyalkyl,

alkoxycarbonylalkyl, arylalkoxycarbonylalkyl,
carbamoylalkyl,

aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl,
alkoxycarbonylaminoalkyl,

alkenyl, cycloalkyl,
cycloalkylalkyl and optionally

substituted aryl, hetaryl, arylalkyl
or hetarylalkyl,

substituents which may be mentioned
being halogen, hydroxyl,

alkyl, alkoxy, nitro or


it being possible for
each radical to be hydrogen or

alkoxy or for both radicals
together to form a 5-, 6- or

7-membered ring which is
optionally interrupted by O, S or

N and which is optionally 
substituted by C
1-4
-alkyl,
B
represents hydroxyl, alkoxy having up to 4
carbon atoms or the radical NR
13
R
14
 in which

R
13
 and R
14
 represent hydrogen, alkyl, aralkyl or
aryl,

and their optical isomers and racemates,

for the preparation of compositions for combating
endoparasites in medicine and veterinary medicine.
Endoparasiticidal compositions, characterized in
that they contain at least one compound of the

formula (I) according to Claim 1.
Process for the preparation of endoparasiticidal
compositions, characterized in that compounds of

the formula (I) according to Claim 1 are mixed with
ex
tenders and/or surfactants.
Use of open-chain octadepsipeptides of the formula
(I) according to Claim 1,

in which

A
represents hydrogen, C
1
-C
4
-alkyl or benzyl
 
or represents a group of the formula -CO-R
15

in which
R
15
represents straight-chain or branched
C
1
-C
4
-alkyl, C
2
-C
4
-alkenyl, C
1
-C
4
-alkoxy or
phenylalkoxy having up to 6 carbon atoms in

the alkyl moiety,
R
1
, R
4
, R
7
 and R
10
,
independently of one another
represent C
1
-C
4
-alkyl, C
3
-C
6
-cycloalkyl or
phenyl-C
1-4
-alkyl,
R
2
, R
5
, R
8
 and R
11
,
independently of one another
represent hydrogen, straight-chain or branched

C
1
-C
8
-alkyl, hydroxy-C
1
-C
6
-alkyl,
C
1
-C
4
-alkanoyloxy-C
1
-C
6
-alkyl,
C
1
-C
4
-alkoxy-C
1
-C
6
-alkyl, aryl-C
1
-C
4
-alkyloxy-C
1
-C
6
-alkyl,
mercapto-C
1
-C
6
-alkyl, C
1
-C
4
-alkylthio-C
1
-C
6
-alkyl,
C
1
-C
4
-alkylsulphinyl-C
1
-C
6
-alkyl,
C
1
-C
4
-alkylsulphonyl-C
1
-C
6
-alkyl,
carboxy- C
1
-C
6
-alkyl, C
1
-C
4
-alkoxycarbonyl-C
1
-C
6
-alkyl,
C
1
-C
4
-arylalkoxycarbonyl-C
1
-C
6
-alkyl,
carbamoyl-C
1
-C
6
-alkyl, amino-C
1
-C
6
-alkyl,
C
1
-C
4
-alkylamino-C
1
-C
6
-alryl,
C
1
-C
4
-dialkylamino-C
1
-C
6
-alkyl,
guanido-C
1
-C
6
-alkyl, C
1
-C
4
-alkoxycarbonylamino-C
1
-C
6
-alkyl,
C
2
-C
8
-alkenyl, C
3
-C
7
-cycloalkyl,
C
3
-C
7
-cycloalkyl-C
1
-C
4
-alkyl or phenylC
1
-C
4
-alkyl 
which can optionally be substituted

by radicals from the series consisting of
halogen, C
1
-C
4
-alkoxyl and C
1
-C
4
-alkyl,
R
3
, R
6
, R
9
 and R
12
independently of one another
represent hydrogen, straight-chain or branched

C
1
-C
8
-alkyl, hydroxy-C
1
-C
6
-alkyl,
C
1
-C
4
-alkanoyloxy-C
1
-C
6
-alkyl, C
1
-C
4
-alkoxy-C
1
-C
6
-alkyl,
aryl-C
1
-C
4
-alkyloxy- C
1
-C
6
-alkyl,
mercapto-C
1
-C
6
-alkyl, C
1
-C
4
-alkylthio-C
1
-C
6
-alkyl,
C
1
-C
4
-alkylsulphinyl-C
1
-C
6
-alkyl,
C
1
-C
4
-alkylsulphonyl-C
1
-C
6
-alkyl, carboxyC
1
-C
6
-alkyl,
C
1
-C
4
-alkoxycarbonyl-C
1
-C
6
-alkyl,
C
1
-C
4
-arylalkoxycarbonyl-C
1
-C
6
-alkyl,
carbamoyl-C
1
-C
6
-alkyl, amino-C
1
-C
6
-alkyl,
C
1
-C
4
-alkylamino-C
1
-C
6
-alkyl, C
1
-C
4
-dialkylamino-C
1
-C
6
-alkyl,
guanido-C
1
-C
6
-alkyl,
C
1
-C
4
-alkoxycarbonylamino-C
1
-C
6
-alkyl,
C
2
-C
8
-alkenyl, C
3
-C
7
-cycloalkyl, C
3
-C
7
-cycloalkyl-C
1
-C
4
-alkyl,
aryl-C
1
-C
4
-alryl or hetaryl-C
1
-C
4
-alkyl,
all of which can optionally be

substituted by radicals selected from the
series consisting of halogen, hydroxyl, C
1
-C
4
-alkoxy,
C
1
-C
4
-alkylyl, nitro or an amino group
of the formula



in which each radical
R
16
 or R
17
 is hydrogen, C
1-4
-alkyl or C
1-4
-alkoxy
or both radicals together can form a 5-, 6- or 

7-membered ring which is optionally
interrupted by O, S or N and which is

optionally substituted by C
1
-C
4
- alkyl, and
B
represents hydroxyl, tert-butoxy or the
radical NR
13
R
14
 where
R
13
 and R
14
independently of one another
represent hydrogen, straight-chain

or branched C
1
-
4
-alkyl, benzyl,
cyclopropyl, cyclohexyl or phenyl,

and their optical isomers and racemates.
Use of open-chain octadepsipeptides of the formula
(I) according to Claim 1

in which

A
represents hydrogen, benzyl or a group COR
15
,
R
15
represents straight-chain or branched alkoxy
or arylalkoxy having up to 6 carbon atoms in

the alkyl moiety,
R
1
, R
4
, R
7
 and R
10
independently of one another
represent C
1-4
-alkyl, C
3-6
-cycloalkyl and
benzyl,
R
2
, R
5
, R
8
 and R
11
,
independently of one another 
represent hydrogen, straight-chain or

branched C
1
-C
8
-alkyl,
C
1
-C
4
-alkanoyloxy-C
1
-C
6
-alkyl,
C
1
-C
4
-alkoxy-C
1
-C
6
-alkyl,
aryl-C
1
-C
4
-alkyloxy-C
1
-C
6
-alkyl,
C
1
-C
4
-alkoxycarbonylamino-C
1
-C
6
-alkyl,
C
2
-C
8
-alkenyl, C
3
-C
7
-cycloalkyl, C
3
-C
7
-cycloalkyl-C
1
-C
4
-alkyl
or phenyl-C
1
-C
4
-alkyl
which can optionally be

substituted by one or more identical or
different radicals from the series

consisting of halogen, methoxy, ethoxy
and methyl,
R
3
, R
6
, R
9
 and R
12
independently of one another
represent hydrogen, straight-chain or

branched C
1
-C
8
-alkyl,
C
1
-C
4
-alkanoyloxy-C
1
-C
6
-alkyl,
C
1
-C
4
-alkoxy-C
1
-C
6
-alkyl,
aryl-C
1
-C
4
-alkyloxy-C
1
-C
6
-alkyl,
C
1
-C
4
-alkoxycarbonylamino-C
1
-C
6
-alkyl,
C
2
-C
8
-alkenyl, C
3
-C
7
-cycloalkyl, C
3
-C
7
-cycloalkyl-C
1
-C
4
-alkyl,
aryl-C
1
-C
4
-alkyl
or hetaryl-C
1
-C
4
-alkyl which can
optionally be substituted by one or more

identical or different radicals from the
series consisting of halogen, methoxy,

ethoxy, nitro or an amino group of the
formula -NR
16
R
17
 where R
16
 and R
17
 are as 
defined in Claim 4,
B
represents hydroxyl or tert-butoxy,

and their optical isomers and racemates.
Use of open-chain octadepsipeptides of the formula
(I) according to Claim 1

in which

A
represents hydrogen or benzyl,
R
1
, R
4
, R
7
 and R
10
independently of one another
represent methyl, ethyl, propyl and i-propyl,
R
2
, R
5
, R
8
 and R
11
,
independently of one another
represent hydrogen, methyl, ethyl,

propyl, isopropyl, butyl, isobutyl, sec-butyl,
pentyl, isopentyl, sec-pentyl,

hexyl, isohexyl, sec-hexyl, heptyl,
isoheptyl, sec-heptyl, octyl, isooctyl,

sec-octyl, allyl, cyclohexylmethyl and
phenylmethyl
,
R
3
, R
6
, R
9
 and R
12
independently of one another
represent hydrogen, methyl, ethyl,

propyl, isopropyl, butyl, isobutyl, secbutyl, 
pentyl, isopentyl, sec-pentyl,

hexyl, isohexyl, sec-hexyl, heptyl,
isoheptyl, sec-heptyl, octyl, isooctyl,

sec-octyl, vinyl, allyl, cyclohexylmethyl,
aryl-C
1
-C
4
-alkyl or hetaryl-C
1
-C
4
-alkyl
which can optionally be substituted

by one or more identical or different
radicals from amongst those given in

Claim 4, and
B
represents hydroxyl or tert-butoxy

and their optical isomers and racemates.
</CLAIMS>
</TEXT>
</DOC>
